Paromomycin loaded solid lipid nanoparticles: Characterization of production parameters

Biotechnology and Bioprocess Engineering

Volumn 16, Issue 3, 2011, Pages 617-623

  Ghadiri, Maryam ^a   Vatanara, Alireza ^b   Doroud, Delaram ^a   Najafabadi, A Roholamini ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug delivery; Lipid nanoparticles; Paromomycin

Indexed keywords

AVERAGE DIAMETER; AVERAGE SIZE; CLINICAL USE; DELIVERY SYSTEMS; EFFICIENT METHOD; ENTRAPMENT EFFICIENCY; FRACTIONAL FACTORIAL DESIGNS; INNOVATIVE METHOD; LIPID NANOPARTICLES; PAROMOMYCIN; PARTICLE SIZE AND ITS DISTRIBUTION; PRODUCTION PARAMETERS; QUANTITATIVE FACTORS; SKIN PENETRATION; SOLID LIPID NANOPARTICLES; SOLVENT DIFFUSION; TWEEN 80; WEIGHT FRACTIONS;

DRUG DELIVERY; EFFICIENCY; MICROEMULSIONS; PALMITIC ACID; STEARIC ACID;

NANOPARTICLES;

LIPID; PAROMOMYCIN; SOLID LIPID NANOPARTICLE; STEARIC ACID;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; MICROEMULSION; PARTICLE SIZE; QUANTITATIVE ANALYSIS;

EID: 80052484165     PISSN: 12268372     EISSN: 19763816     Source Type: Journal    
DOI: 10.1007/s12257-010-0331-5     Document Type: Article

References (25)

1. Desjeux, P. (1992) Human leishmaniases: Epidemiology and public health aspects. World Health Stat. Q. 45: 267-75.
2. Richens, J. (2004) Genital manifestations of tropical diseases. Sex Transm. Infect. 80: 12-17. (Pubitemid 38221890)
3. Bryceson ADM. (1987) Therapy in man. In: Peters W, Killick- Kendrick R editor. The Leishmaniasis in Biology and Medicine. volume 2: London: Academic Press; p. 847-907.
4. Garnier, T. and S. L. Croft (2002) Topical treatment for cutaneous leishmaniasis. Curr. Opin. Investig. Drugs 3: 538-544.
5. Asilian, A., A. Sadeghinia, G. Faghihi, A. Momeni, and A. Amini Harandi (2003) The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Ann. Trop Med. Parasitol. 97: 493-498. (Pubitemid 36898085)
6. Guerin, P. J., P. Olliaro, S. Sundar, M. Boelaert, and S. L. Croft (2002) Visceral leishmaniasis: Current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2: 494-501. (Pubitemid 34826855)
7. Tulkens, P. M. (1991) Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 10: 100-106.
8. Armijos, R. X., M. M. Weigel, M. Calvopina, M. Mancheno, and R. Rodriguez (2004) Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop. 91: 153-160. (Pubitemid 38952716)
9. Ferreira, L. S., G. A. Ramaldes, E. A. Nunan, and L. A. M. Ferreira (2004) In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis. Drug Dev. Ind. Pharm. 30: 289-296. (Pubitemid 38451753)
10. Mauel, J. (1990) Macrophage parasite interactions in Leishmania infections. J. Leukoc. Biol. 47: 187-193. (Pubitemid 20061673)
11. Food Drug Cosmetic Law Reports, (1994) Commerce Clearing House Inc.
12. Mehnert, W. and K. Mader (2001) Solid lipid nanoparticles production characterization and applications. Adv. Drug Deliv. Rev. 47: 165-196. (Pubitemid 32324113)
13. Liu, J., W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang (2007) Isotretinoin- loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328: 191-195. (Pubitemid 44880576)
14. Mei, Z., H. Chen, T. Wang, Y. Yang, and X. Yang (2003) Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56: 189-196. (Pubitemid 37072102)
15. Li, Y., L. Dong, A. Jia, X. Chang, and H. Xue (2006) Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int. J. Biol. Macromol. 38: 296-299.
16. Montgomery, D. C. (1991) Design and analysis of experiments. 3rd ed. John Wiley & Sons, NY.
17. Pick, J., L. Olson, W. Ellis, and P. Lim (1997) Development and validation of a method to extract and quantitate paromomycin and gentamicin from an Aquaphilic cream formulation. J. Pharm. Biomed. Anal. 16: 131-137. (Pubitemid 27462696)
18. Lv, Q., A. Yu, Y. Xi, H. Li, Z. Song, J. Cui, F. Cao, and G. Zhai (2009) Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm. 372: 191-198.
19. Attama, A. A. and C. C. Muller- Goymann (2008) Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf. A: Physicochem. Eng. Asp. 315: 189-195. (Pubitemid 350298854)
20. You, J., F. Wan, F. Cui, Y. Sun, Y. Du, and F. Hu (2007) Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int. J. Pharm. 343: 270-276. (Pubitemid 47321031)
21. You, J., F. Wan, Y. Sun, X. Zhang, F. Cui, Y. Du, H. Yuan, and F. Hu (2008) Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): Preparation and evaluation in vitro. Int. J. Pharma. 359: 104-110.
22. Triplett, M. D. and J. F. Rathman (2009) Optimization of b-car otene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. J. Nanopart. Res. 11: 601-614.
23. Yuan, H., L. F. Huang, Y. Z. Du, X. Y. Ying, J. You, F. Q. Hu, and S. Zeng (2007) Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids and Surfaces B: Biointerfaces 61: 132-137.
24. Arcamone, M. and V. Guiseppe Cassinelli (1977) Paromomycin derivatives and process for the preparation thereof. US patent 4,021,601.
25. Wahlig, H., E. Dingeldein, and R. Kirchlechner (1986) Flavonoid phosphate salts of aminoglycoside antibiotics. US patent 4,617,293.